| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| gL(L) | 716 | 75.2% | -1.37 | 277 | 82.0% |
| CentralBrain-unspecified | 73 | 7.7% | -1.33 | 29 | 8.6% |
| PLP(L) | 59 | 6.2% | -inf | 0 | 0.0% |
| CRE(L) | 18 | 1.9% | -0.08 | 17 | 5.0% |
| b'L(L) | 20 | 2.1% | -0.86 | 11 | 3.3% |
| PED(L) | 28 | 2.9% | -3.22 | 3 | 0.9% |
| SCL(L) | 28 | 2.9% | -4.81 | 1 | 0.3% |
| CA(L) | 8 | 0.8% | -inf | 0 | 0.0% |
| a'L(L) | 1 | 0.1% | -inf | 0 | 0.0% |
| bL(L) | 1 | 0.1% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns KCg | % In | CV |
|---|---|---|---|---|---|
| KCg-d (L) | 92 | DA | 314 | 34.9% | 0.7 |
| KCg-m (L) | 108 | DA | 162 | 18.0% | 0.6 |
| APL (L) | 1 | GABA | 80 | 8.9% | 0.0 |
| KCg-s2 (L) | 1 | DA | 52 | 5.8% | 0.0 |
| aMe12 (L) | 4 | ACh | 33 | 3.7% | 0.1 |
| PAM08 (L) | 11 | DA | 32 | 3.6% | 0.6 |
| PPL103 (R) | 1 | DA | 22 | 2.4% | 0.0 |
| KCg-s3 (L) | 1 | DA | 19 | 2.1% | 0.0 |
| KCg-s1 (L) | 1 | DA | 19 | 2.1% | 0.0 |
| DPM (L) | 1 | DA | 18 | 2.0% | 0.0 |
| PAM01 (L) | 10 | DA | 14 | 1.6% | 0.5 |
| aMe12 (R) | 2 | ACh | 13 | 1.4% | 0.8 |
| PPL103 (L) | 1 | DA | 10 | 1.1% | 0.0 |
| PPL101 (L) | 1 | DA | 8 | 0.9% | 0.0 |
| M_lPNm13 (L) | 2 | ACh | 8 | 0.9% | 0.0 |
| PAM08 (R) | 6 | DA | 7 | 0.8% | 0.3 |
| PAM07 (L) | 5 | DA | 7 | 0.8% | 0.3 |
| PAM12 (L) | 4 | DA | 6 | 0.7% | 0.3 |
| KCg-s4 (L) | 1 | DA | 5 | 0.6% | 0.0 |
| PAM01 (R) | 4 | DA | 5 | 0.6% | 0.3 |
| VP1d_il2PN (L) | 1 | ACh | 4 | 0.4% | 0.0 |
| PPL202 (L) | 1 | DA | 4 | 0.4% | 0.0 |
| OA-VPM4 (R) | 1 | OA | 4 | 0.4% | 0.0 |
| MeVPLo2 (L) | 2 | ACh | 4 | 0.4% | 0.0 |
| KCa'b'-ap2 (L) | 4 | DA | 4 | 0.4% | 0.0 |
| PAM05 (L) | 1 | DA | 3 | 0.3% | 0.0 |
| PAM12 (R) | 2 | DA | 3 | 0.3% | 0.3 |
| LHPV2a1_a (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| LoVP38 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| MeVPLo2 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| MBON09 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| VP1d_il2PN (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| MeVP43 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| aMe5 (L) | 2 | ACh | 2 | 0.2% | 0.0 |
| KCa'b'-ap1 (L) | 2 | DA | 2 | 0.2% | 0.0 |
| MBON26 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe23 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MBON29 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MBON09 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| SMP208 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHAV2g5 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| OA-VPM3 (L) | 1 | OA | 1 | 0.1% | 0.0 |
| PAM15 (R) | 1 | DA | 1 | 0.1% | 0.0 |
| PAM06 (L) | 1 | DA | 1 | 0.1% | 0.0 |
| PAM02 (L) | 1 | DA | 1 | 0.1% | 0.0 |
| M_lPNm11A (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP44 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PAM07 (R) | 1 | DA | 1 | 0.1% | 0.0 |
| M_lPNm11C (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| FB5K (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| M_lPNm11D (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP21 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aIPg1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe9 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MBON12 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| VL1_ilPN (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MBON31 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| OA-VUMa3 (M) | 1 | OA | 1 | 0.1% | 0.0 |
| downstream partner | # | NT | conns KCg | % Out | CV |
|---|---|---|---|---|---|
| KCg-d (L) | 83 | DA | 262 | 25.9% | 0.6 |
| KCg-m (L) | 109 | DA | 161 | 15.9% | 0.6 |
| APL (L) | 1 | GABA | 49 | 4.8% | 0.0 |
| MBON09 (L) | 2 | GABA | 47 | 4.6% | 0.1 |
| PAM08 (L) | 13 | DA | 44 | 4.3% | 0.9 |
| MBON01 (L) | 1 | Glu | 36 | 3.6% | 0.0 |
| DPM (L) | 1 | DA | 35 | 3.5% | 0.0 |
| MBON05 (R) | 1 | Glu | 33 | 3.3% | 0.0 |
| MBON27 (L) | 1 | ACh | 28 | 2.8% | 0.0 |
| MBON32 (L) | 1 | GABA | 28 | 2.8% | 0.0 |
| KCg-s2 (L) | 1 | DA | 27 | 2.7% | 0.0 |
| MBON11 (L) | 1 | GABA | 24 | 2.4% | 0.0 |
| PAM01 (L) | 10 | DA | 17 | 1.7% | 0.9 |
| KCg-s3 (L) | 1 | DA | 15 | 1.5% | 0.0 |
| MBON33 (L) | 1 | ACh | 12 | 1.2% | 0.0 |
| MBON04 (R) | 1 | Glu | 11 | 1.1% | 0.0 |
| PAM08 (R) | 6 | DA | 11 | 1.1% | 0.4 |
| KCg-s1 (L) | 1 | DA | 10 | 1.0% | 0.0 |
| PPL103 (R) | 1 | DA | 10 | 1.0% | 0.0 |
| MBON35 (L) | 1 | ACh | 10 | 1.0% | 0.0 |
| PAM01 (R) | 6 | DA | 9 | 0.9% | 0.5 |
| PAM07 (L) | 4 | DA | 8 | 0.8% | 0.6 |
| PAM12 (L) | 5 | DA | 8 | 0.8% | 0.3 |
| MBON20 (L) | 1 | GABA | 7 | 0.7% | 0.0 |
| MBON12 (L) | 2 | ACh | 7 | 0.7% | 0.4 |
| PPL103 (L) | 1 | DA | 5 | 0.5% | 0.0 |
| MBON21 (L) | 1 | ACh | 5 | 0.5% | 0.0 |
| PAM12 (R) | 4 | DA | 5 | 0.5% | 0.3 |
| KCa'b'-ap2 (L) | 4 | DA | 5 | 0.5% | 0.3 |
| MBON30 (L) | 1 | Glu | 4 | 0.4% | 0.0 |
| KCg-s4 (L) | 1 | DA | 4 | 0.4% | 0.0 |
| CRE022 (L) | 1 | Glu | 3 | 0.3% | 0.0 |
| MBON26 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| OA-VPM4 (R) | 1 | OA | 3 | 0.3% | 0.0 |
| PPL101 (L) | 1 | DA | 3 | 0.3% | 0.0 |
| LAL159 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| PAM05 (L) | 2 | DA | 3 | 0.3% | 0.3 |
| PAM07 (R) | 2 | DA | 3 | 0.3% | 0.3 |
| CRE200m (R) | 2 | Glu | 3 | 0.3% | 0.3 |
| KCa'b'-ap1 (L) | 3 | DA | 3 | 0.3% | 0.0 |
| SMP058 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| MBON29 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| PAM15 (R) | 1 | DA | 2 | 0.2% | 0.0 |
| FB4K (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| LHPV2g1 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| MBON22 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| PPL101 (R) | 1 | DA | 2 | 0.2% | 0.0 |
| PAM06 (L) | 2 | DA | 2 | 0.2% | 0.0 |
| PAM02 (L) | 2 | DA | 2 | 0.2% | 0.0 |
| SMP376 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MBON29 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE080_c (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE012 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CRE042 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| MBON05 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB1357 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE054 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CB1361 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CRE081 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB2736 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SMP174 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL129 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LAL043_a (L) | 1 | unc | 1 | 0.1% | 0.0 |
| CB2018 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CRE065 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE072 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE024 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP714m (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPD2c7 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MBON24 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP384 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| LAL100 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| LAL100 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| PPL102 (R) | 1 | DA | 1 | 0.1% | 0.0 |
| CRE048 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| AVLP562 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE107 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHCENT3 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LAL198 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| OA-VUMa6 (M) | 1 | OA | 1 | 0.1% | 0.0 |
